FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Alter Jeffrey D.
2. Issuer Name and Ticker or Trading Symbol

Anthem, Inc. [ ANTM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, IngenioRx & Anthem Health
(Last)          (First)          (Middle)

220 VIRGINIA AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

10/1/2020
(Street)

INDIANAPOLIS, IN 46204
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/1/2020  A  2746 (1)A$0 2746 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) $270.17 10/1/2020  A   10659     (2)10/1/2030 Common Stock 10659.0 $0 10659 D  

Explanation of Responses:
(1) Represents restricted share units. Restrictions lapse as follows: 915 shares each on 10/1/2021 and 10/1/2022, and 916 shares on 10/1/2023.
(2) The option represents a right to purchase a total of 10,659 shares, and is exercisable in three annual installments of 3,553 shares each, beginning on 10/1/2021, which is the one-year anniversary of the option grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Alter Jeffrey D.
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204


EVP, IngenioRx & Anthem Health

Signatures
/s/ Kathleen S. Kiefer, Attorney in fact10/5/2020
**Signature of Reporting PersonDate

Anthem (NYSE:ANTM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Anthem Charts.
Anthem (NYSE:ANTM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Anthem Charts.